Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
62
MNMD Quote, Financials, Valuation and Earnings
Last price:
$12.90
Seasonality move
:
42.06%
Day range:
$12.01 - $12.68
52-week range:
$4.70 - $14.43
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.32x
Volume:
1.4M
Avg. volume:
1.8M
1-year change:
73.7%
Market cap:
$1.2B
Revenue:
--
EPS (TTM):
-$1.97
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed), Inc.
|
-- | -$0.50 | -- | -29.43% | $25.64 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
ELMD
Electromed, Inc.
|
$16.6M | -- | 11.04% | -- | $36.00 |
|
MYO
Myomo, Inc.
|
$9.4M | -$0.11 | -13.8% | -1168.66% | $5.00 |
|
VNRX
VolitionRX Ltd.
|
$806.3K | -$0.04 | 272.5% | -33.67% | $2.60 |
|
XTNT
Xtant Medical Holdings, Inc.
|
$28.5M | -- | 2.34% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed), Inc.
|
$12.35 | $25.64 | $1.2B | -- | $0.00 | 0% | -- |
|
CATX
Perspective Therapeutics, Inc.
|
$2.4000 | $12.3077 | $178.4M | -- | $0.00 | 0% | 162.73x |
|
ELMD
Electromed, Inc.
|
$27.81 | $36.00 | $231.9M | 29.92x | $0.00 | 0% | 3.71x |
|
MYO
Myomo, Inc.
|
$1.04 | $5.00 | $40M | -- | $0.00 | 0% | 1.02x |
|
VNRX
VolitionRX Ltd.
|
$0.30 | $2.60 | $36.8M | -- | $0.00 | 0% | 20.54x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.62 | $1.50 | $86.2M | 60.39x | $0.00 | 0% | 0.67x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed), Inc.
|
23.62% | 2.471 | 4.46% | 3.20x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
ELMD
Electromed, Inc.
|
-- | 1.217 | -- | 4.58x |
|
MYO
Myomo, Inc.
|
45.68% | -2.855 | 35.87% | 1.94x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNMD
Mind Medicine (MindMed), Inc.
|
-- | -$45.7M | -70.5% | -80.63% | -- | -$29.8M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
MYO
Myomo, Inc.
|
$6.4M | -$3.5M | -46.49% | -68.35% | -34.86% | -$2.9M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Mind Medicine (MindMed), Inc. vs. Competitors
-
Which has Higher Returns MNMD or CATX?
Perspective Therapeutics, Inc. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of -12425.36%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About MNMD or CATX?
Mind Medicine (MindMed), Inc. has a consensus price target of $25.64, signalling upside risk potential of 107.58%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 412.82%. Given that Perspective Therapeutics, Inc. has higher upside potential than Mind Medicine (MindMed), Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Mind Medicine (MindMed), Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.8 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is MNMD or CATX More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.792, which suggesting that the stock is 179.161% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock MNMD or CATX?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or CATX?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than Perspective Therapeutics, Inc. quarterly revenues of $209K. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 162.73x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M CATXPerspective Therapeutics, Inc.162.73x -- $209K -$26M
-
Which has Higher Returns MNMD or ELMD?
Electromed, Inc. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of 12.65%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About MNMD or ELMD?
Mind Medicine (MindMed), Inc. has a consensus price target of $25.64, signalling upside risk potential of 107.58%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 29.45%. Given that Mind Medicine (MindMed), Inc. has higher upside potential than Electromed, Inc., analysts believe Mind Medicine (MindMed), Inc. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.8 0 0 ELMDElectromed, Inc.4 0 0 -
Is MNMD or ELMD More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.792, which suggesting that the stock is 179.161% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.
-
Which is a Better Dividend Stock MNMD or ELMD?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or ELMD?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than Electromed, Inc.'s net income of $2.1M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 29.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 3.71x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M ELMDElectromed, Inc.3.71x 29.92x $16.9M $2.1M
-
Which has Higher Returns MNMD or MYO?
Myomo, Inc. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of -36.3%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat Myomo, Inc.'s return on equity of -68.35%.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M MYOMyomo, Inc.63.84% -$0.09 $26.9M -
What do Analysts Say About MNMD or MYO?
Mind Medicine (MindMed), Inc. has a consensus price target of $25.64, signalling upside risk potential of 107.58%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 380.77%. Given that Myomo, Inc. has higher upside potential than Mind Medicine (MindMed), Inc., analysts believe Myomo, Inc. is more attractive than Mind Medicine (MindMed), Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.8 0 0 MYOMyomo, Inc.4 0 0 -
Is MNMD or MYO More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.792, which suggesting that the stock is 179.161% more volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.
-
Which is a Better Dividend Stock MNMD or MYO?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or MYO?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than Myomo, Inc. quarterly revenues of $10.1M. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than Myomo, Inc.'s net income of -$3.7M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 1.02x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M MYOMyomo, Inc.1.02x -- $10.1M -$3.7M
-
Which has Higher Returns MNMD or VNRX?
VolitionRX Ltd. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of -862.39%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About MNMD or VNRX?
Mind Medicine (MindMed), Inc. has a consensus price target of $25.64, signalling upside risk potential of 107.58%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 767.53%. Given that VolitionRX Ltd. has higher upside potential than Mind Medicine (MindMed), Inc., analysts believe VolitionRX Ltd. is more attractive than Mind Medicine (MindMed), Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.8 0 0 VNRXVolitionRX Ltd.4 2 0 -
Is MNMD or VNRX More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.792, which suggesting that the stock is 179.161% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock MNMD or VNRX?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or VNRX?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 20.54x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M VNRXVolitionRX Ltd.20.54x -- $627.3K -$5.4M
-
Which has Higher Returns MNMD or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -- compared to Mind Medicine (MindMed), Inc.'s net margin of 3.93%. Mind Medicine (MindMed), Inc.'s return on equity of -80.63% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital MNMDMind Medicine (MindMed), Inc.-- -$0.78 $171M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About MNMD or XTNT?
Mind Medicine (MindMed), Inc. has a consensus price target of $25.64, signalling upside risk potential of 107.58%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 143.51%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Mind Medicine (MindMed), Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Mind Medicine (MindMed), Inc..
Company Buy Ratings Hold Ratings Sell Ratings MNMDMind Medicine (MindMed), Inc.8 0 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is MNMD or XTNT More Risky?
Mind Medicine (MindMed), Inc. has a beta of 2.792, which suggesting that the stock is 179.161% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock MNMD or XTNT?
Mind Medicine (MindMed), Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mind Medicine (MindMed), Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNMD or XTNT?
Mind Medicine (MindMed), Inc. quarterly revenues are --, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Mind Medicine (MindMed), Inc.'s net income of -$67.3M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Mind Medicine (MindMed), Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mind Medicine (MindMed), Inc. is -- versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNMDMind Medicine (MindMed), Inc.-- -- -- -$67.3M XTNTXtant Medical Holdings, Inc.0.67x 60.39x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 33.49% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 42.66% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 10.18% over the past day.
